Deutsche Bank’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,801
| Closed | -$56.3K | – | 3520 |
|
|
2024
Q1 | $56.3K | Hold |
29,801
| – | – | ﹤0.01% | 3321 |
|
|
2023
Q4 | $78.7K | Buy |
29,801
+27,452
| +1,169% | +$72.5K | ﹤0.01% | 3279 |
|
|
2023
Q3 | $5.4K | Buy |
+2,349
| New | +$5.4K | ﹤0.01% | 3542 |
|
|
2022
Q2 | – | Sell |
-22,300
| Closed | -$108K | – | 3985 |
|
|
2022
Q1 | $108K | Sell |
22,300
-1,135
| -5% | -$5.5K | ﹤0.01% | 3517 |
|
|
2021
Q4 | $265K | Buy |
23,435
+600
| +3% | +$6.79K | ﹤0.01% | 3196 |
|
|
2021
Q3 | $333K | Sell |
22,835
-8,890
| -28% | -$130K | ﹤0.01% | 3263 |
|
|
2021
Q2 | $370K | Buy |
31,725
+3,235
| +11% | +$37.7K | ﹤0.01% | 3396 |
|
|
2021
Q1 | $348K | Sell |
28,490
-9,161
| -24% | -$112K | ﹤0.01% | 3307 |
|
|
2020
Q4 | $471K | Buy |
37,651
+13,405
| +55% | +$168K | ﹤0.01% | 2923 |
|
|
2020
Q3 | $365K | Buy |
24,246
+6,214
| +34% | +$93.5K | ﹤0.01% | 2806 |
|
|
2020
Q2 | $442K | Buy |
18,032
+10,865
| +152% | +$266K | ﹤0.01% | 2693 |
|
|
2020
Q1 | $102K | Sell |
7,167
-77
| -1% | -$1.1K | ﹤0.01% | 3191 |
|
|
2019
Q4 | $114K | Buy |
7,244
+1,484
| +26% | +$23.4K | ﹤0.01% | 3455 |
|
|
2019
Q3 | $46K | Sell |
5,760
-8,049
| -58% | -$64.3K | ﹤0.01% | 3853 |
|
|
2019
Q2 | $123K | Sell |
13,809
-9,014
| -39% | -$80.3K | ﹤0.01% | 3985 |
|
|
2019
Q1 | $175K | Sell |
22,823
-271
| -1% | -$2.08K | ﹤0.01% | 3971 |
|
|
2018
Q4 | $107K | Sell |
23,094
-17,057
| -42% | -$79K | ﹤0.01% | 4044 |
|
|
2018
Q3 | $364K | Buy |
40,151
+6,280
| +19% | +$56.9K | ﹤0.01% | 3881 |
|
|
2018
Q2 | $402K | Buy |
33,871
+22,442
| +196% | +$266K | ﹤0.01% | 3888 |
|
|
2018
Q1 | $159K | Buy |
+11,429
| New | +$159K | ﹤0.01% | 4164 |
|